DataKnowledgeCloudtrainingcoordination

L1000 LINCS DCIC TAK003 A375 96H A24 HLA-A.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

A375

Subject (Entity type)

Project:

L1000-Phase1

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Disease:

melanoma

Disease (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC TAK003 A375 96H A24 HLA-A

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Anatomy:

skin of body

Anatomy (Entity type)

Uncompressed Size In Bytes:756 KB

Size In Bytes:277 KB

Sha256:cd45a849d10ad7ed4403e7704f2ebc739d90d91d20adb53e64eaed5aec597da0

Persistent Id:drs://drs.lincs-dcic.org/0f17b54b1a7ffe54cb4b74432c4ac8b8

Mime Type:application/gzip

Md5:0f17b54b1a7ffe54cb4b74432c4ac8b8

Filename:L1000_LINCS_DCIC_TAK003_A375_96H_A24_HLA-A.tsv.gz

Creation Time:2017-03-03T00:00:00

Access Url:

drs://drs.lincs-dcic.org/0f17b54b1a7ffe54cb4b74432c4ac8b8

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC TAK003 A375 96H A24 HLA-A Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase1 project

L1000 LINCS DCIC TAK003 A375 96H A24 HLA-A

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase1 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.